Rhodi..your words.19 Feb 2020 09:28
Are no more than sand castles waiting for the tide to wash them away.
"Interesting if you listen back or read the transcripts of the last few webcasts as imo JAK actually appears to make a give away as to an aspect of certain news before correcting the sentence. Happily to say that today I bought a few more on that observation and a few other snippets within the recent news. Yes very content here and this imo will hit £1.50 and £2.00 and then the sky is the limit. "
"if this got to £2 sp as I see that as the derisked number where I would expect to see the investment safe and probably go treble that sp by 2022."
So as we stand, with a market price of £67 million, you think that this company has the potential to reach around £600 million by 2022 ....and that's taken into account, that the company is running out of funds, has many years of trials ahead ( if it ever gets the funding for ) whilst having only one unproven drug that so far hasn't had outstanding results that may even merit a slight rise in the sp.
Rhodi, if your going to ramp a share, try make it sound a tad realistic..gla